FUCHS ANNOUNCES HACCP AND ISO 22000-APPROVED FOOD AND PHARMACEUTICAL PROCESSING CLEANER

FUCHS Lubricants has announced a heavy duty water-based cleaner concentrate for the food and pharmaceutical processing industry that is solvent free, readily biodegradable and environmentally friendly. BIO CLEAN assists facilities with meeting the highest food industry standards, and especially HACCP (Hazard Analysis and Critical Control Point) and ISO 22000. BIO CLEAN and the PREMIX are also NSF registered. “While the product’s reputation originated in the food industry, it has been embraced by the commercial and mining sectors, and is suitable for all environments,” explained Giles Cutter, Lubritech Divisional Manager, FUCHS…

Read More

Tetra Pak Introduces 14 State-of-the-Art Lines for Cheese Manufacturers

Proven solutions based on expertise and technology for Mozzarella, Semi-hard cheese, Cheddar and Fresh cheese production – as research reveals that a third of consumers have increased their cheese consumption during the pandemic   Johannesburg, South Africa (11, May 2021) – Tetra Pak announces the development of 14 new Best Practice Lines (BPLs)1 for cheese manufacturers, the latest of which – specifically customised for Cottage cheese – launched today. The other cheeses that will benefit from these BPLs include Mozzarella, Semi-hard cheese, Cheddar, and Fresh cheese production. Together, these cheese…

Read More

The investment case for SA drug manufacturing

President Cyril Ramaphosa recently addressed the nation about his economic reconstruction and recovery plan. One of the proposals for job creation is a focus on reversing the decline in local manufacturing. The pharmaceutical sector has sadly been a prime example of this trend. Although the economic argument for reviving local manufacturing is a compelling one, it is not the only one. Alarmingly for us, over the past 15 years, South Africa has seen 40 pharmaceutical manufacturing facilities close. Most of these facilities were owned by multinational companies and manufactured their…

Read More

SA’s Biovac in talks to manufacture Covid-19 vaccines

  In the past Biovac has partnered with companies like Pfizer and Sanofi. By Wendell Roelf and Alexander Winning, Reuters 14 Oct 2020  12:14 Image: Shutterstock A South African company part-owned by the government is in talks with the global Covid-19 vaccine distribution scheme and pharmaceutical companies to produce some of the vaccines the country needs to protect itself against the disease. The Biovac Institute, a Cape Town-based joint venture between the government and private sector, could produce up to 30 million doses of Covid-19 vaccines per year, depending on the technology involved,…

Read More

Pharmaceutical manufacturing companies must handle returned drugs better

Pharmaceutical manufacturers should focus on reducing faults and working closely with pharmacies to manage medicine stocks better. But the return of medicine can’t be avoided. It’s inevitable that some products would be returned because of faults or when they have expired. Most drug returns are caused by recalls. A recall is typically done by the manufacturer. It’s different from a return of pharmaceutical products by customers. Whatever the reason for the return, manufacturers, importers, retailers, exporters and end-users must follow strict requirements for the removal of waste. In the normal…

Read More

What South Africa is doing to protect and share traditional medicine resources

  African traditional medicine is gaining attention and innovation interest despite the advances in modern medicine. Most of the continent’s population use traditional medicine for at least some of their healthcare needs.   The Faraday Muti Market, a popular African traditional medicine market in downtown Johannesburg. Hoberman Collection/Universal Images Group via Getty Images What South Africa is doing to protect and share traditional medicine resources There are still many communities whose traditional knowledge is not recognised. But a number of African countries are recognising the need to protect traditional knowledge. They are putting policies…

Read More

Aspen’s pot of gold

    Aspen’s latest divestment brings its sales tally to R30bn in 18 months, bringing its debt under control and putting the group on a surer footing for growth — management says. Africa’s largest drug company, the JSE-listed Aspen, has sold the rights for its European thrombosis business to US pharmaceutical firm Mylan for R12.6-billion. It has, however, retained its thrombosis business in its core emerging markets including South-East Asia and sub-Saharan Africa. This is likely the last of the major disposals intended to refocus the business and cut debt.…

Read More

Novavax begins mid-stage study of Covid-19 vaccine in South Africa

Aug 17 (Reuters) – U.S. drug developer Novavax Inc said on Monday that it is starting a mid-stage study of its experimental COVID-19 vaccine in South Africa, as the country experiences a surge in coronavirus cases. The Phase 2b trial study of NVX-CoV2373 will be conducted on about 2,665 healthy adults and will evaluate the safety and immunogenicity in about 240 medically stable, HIV-positive adults, the company said in a statement. “Because South Africa is experiencing a winter surge of COVID-19 disease, this important Phase 2b clinical trial has the…

Read More

Medicines for All Institute partners with South African manufacturer to increase access to lifesaving drugs

  The Medicines for All Institute has entered into a partnership with a manufacturer in South Africa to commercialize advances made by the institute to improve access to lifesaving medications for HIV/AIDS and other diseases. The institute, which has successfully developed cost-saving formulas for key anti-HIV drugs, is based at Virginia Commonwealth University and its College of Engineering in Richmond, Virginia. Officials at VCU and Chemical Process Technologies Pharma Ltd. recently signed a three-year agreement outlining their collaboration. The South African company will validate and scale up processes developed by…

Read More

Indigenous cosmetic brands are taking off in SA

Looking pretty is serious business, with the sector continuing to register good growth. Image: Waldo Swiegers, Bloomberg A struggling economy doesn’t necessarily mean makeup products will be left on the store shelf, but those shopping for cosmetics are increasingly looking for more affordable and organic brands. According to market research firm Euromonitor International, although consumers are cutting back on non-essential goods, beauty and personal care products continue to register good growth, despite the challenges in the market. “On the demand side, a strong personal grooming trend where greater importance was attached…

Read More